不同组织硬度脑膜瘤的微小RNA分析:有效术前规划的潜在工具
该研究在布尔诺大学医院纳入手术治疗的脑膜瘤患者,对肿瘤组织行小RNA测序分析微小RNA表达,鉴定不同硬度脑膜瘤中差异表达的微小RNA,并用逆转录定量聚合酶链反应验证;miR-31-5p与肿瘤组织硬度的关联最为显著(敏感性=71%,特异性=83%)。
要点
- 不同硬度脑膜瘤存在差异表达的微小RNA。
- miR-31-5p和miR-34b-5p在较硬脑膜瘤中显著上调。
- miR-31-5p与肿瘤组织硬度关联最显著,敏感性=71%、特异性=83%。
核心结论
- 本研究提示微小RNA有潜力作为判断脑膜瘤组织硬度的生物标志物。
- 识别与肿瘤一致性相关的特定微小RNA可能改善术前规划和患者预后。
- 这些发现为进一步探索微小RNA在脑膜瘤临床评估中的应用奠定了基础。
研究设计与样本
- 研究纳入在布尔诺大学医院接受手术治疗的脑膜瘤患者。
- 从肿瘤组织样本中分离总RNA,经质量控制后行小RNA测序分析微小RNA表达。
- 鉴定差异表达的微小RNA,并评估其与肿瘤硬度的关联。
- 采用逆转录定量聚合酶链反应对结果进行验证。
主要发现
- 研究鉴定出在不同硬度脑膜瘤中差异表达的特定微小RNA。
- miR-31-5p和miR-34b-5p等关键微小RNA在较硬脑膜瘤中显著上调。
- 逆转录定量聚合酶链反应验证结果提示微小RNA表达与肿瘤一致性之间存在潜在联系。
- miR-31-5p的表达与肿瘤组织硬度的关联最为显著(敏感性=71%,特异性=83%)。
关键数值与推荐
- miR-31-5p与肿瘤组织硬度关联的敏感性=71%、特异性=83%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Meningioma, the most common primary intracranial tumor, presents challenges in surgical treatment because of varying tissue stiffness. This study explores the molecular background of meningioma stiffness, a critical factor in surgical planning and prognosis, focusing on the utility of microRNAs (miRNAs) as diagnostic biomarkers of tissue stiffness. METHODS: Patients with meningiomas treated surgically at the University Hospital Brno were included in this study. Total RNA, isolated from tumor tissue samples, underwent quality control and small RNA sequencing to analyze miRNA expression. Differentially expressed miRNAs were identified, and their association with tumor stiffness was assessed. RESULTS: This study identified specific miRNAs differentially expressed in meningiomas with different stiffness levels. Key miRNAs, such as miR-31-5p and miR-34b-5p, showed significant upregulation in stiffer meningiomas. These findings were validated using reverse transcription-quantitative polymerase chain reaction, revealing a potential link between miRNA expression and tumor consistency. The expression of miR-31-5p was most notably associated with the stiffness of the tumor tissue (sensitivity = 71% and specificity = 83%). CONCLUSION: This research highlights the potential of miRNAs as biomarkers for determining meningioma tissue stiffness. Identifying specific miRNAs associated with tumor consistency could improve preoperative planning and patient prognosis. These findings pave the way for further exploration of miRNAs in the clinical assessment of meningiomas.
引用
- Duba M, Al Tukmachi D, Samoilenko T, et al. MicroRNA Analysis in Meningiomas with Different Degrees of Tissue Stiffness: A Potential Tool for Effective Preoperative Planning. Neurosurgery. 2024. PMID: 39485054. doi:10.1227/neu.0000000000003222
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。